NEW YORK (GenomeWeb News) – Proteomics technologies company LifeSensors has licensed technology from Spain's CICbioGUNE research center for use in purifying ubiquitylated proteins that are unstable and difficult to characterize.

LifeSensors said on Tuesday that it signed a worldwide, exclusive license for the Tandem-repeated Ubiquitin Binding Entities (TUBEs) technology, which was developed at CICbioGUNE's proteomics unit.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.